Bacchus D to be sold as quasi-drug
Published: 2011-10-10 06:58:00
Updated: 2011-10-10 06:58:00
The Korea Food and Drug Administration says that Dong-A Pharmaceutical’s Bacchus-D was reclassified into one of the quasi-drugs last month, although the company has pledged to provide Bacchus-F to retailers and Bacchus-D to pharmacies.
Ending weeks of silence over whether it would provide Bacc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.